NCT04160260View on ClinicalTrials.gov

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

March 23, 2020

Study Completion Date

April 13, 2020

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Omadacycline

Omadacycline: PO Tablets

Trial Locations (13)

33155

Site 108, Miami

33165

Site 110, Miami

33166

Site 106, Doral

33409

Site 112, West Palm Beach

33756

Site 111, Clearwater

Site 116, Clearwater

35215

Site 105, Birmingham

53717

Site 109, Madison

59701

Site 103, Butte

75092

Site 101, Sherman

89106

Site 114, Las Vegas

92123

Site 102, San Diego

Site 104, San Diego

Sponsors
All Listed Sponsors
lead

Paratek Pharmaceuticals Inc

INDUSTRY